Alkem Laboratories has denied allegations by the CDSCO that certain batches of its products, Pan-D and Clavam 625, failed to meet quality standards. The company asserted that the samples in question were fake after comparing them with actual batches. Alkem’s stock price saw a slight decline before closing marginally lower.
Related Posts
In a booster to Make in India, Dixon to form JV with Vivo India for manufacturing smartphones
Vivo India and Dixon Technologies are forming a joint venture for contract manufacturing electronics, including smartphones. Dixon will hold a 51% stake. The partnership aims […]
Hyderabad HRTech unicorn Darwinbox elevates CTO as fourth co-founder
Darwinbox, a leading HRTech startup from Hyderabad, has promoted its CTO Vineet Singh to co-founder. Since joining in 2015, Singh has been instrumental in the […]
HPCL shares jump nearly 5% as net profit more than triples in Q3
- staff
- January 24, 2025
- 0
Hindustan Petroleum Corporation Ltd (HPCL) shares surged nearly 5% after the company posted a more than threefold increase in December quarter net profit. The profit […]